| Model | Selected organism on KEGG | Selected organism on BioCyc |
|---|---|---|
| e_coli_core | Entire database | MetaCyc (Tier 1) |
| Model | Number of compartments |
|---|---|
| e_coli_core | 2 |
| Model | Total | bigg | biocyc | cas | chebi | chemspider | drugbank | envipath | hmdb | inchi | inchi_key | kegg | knapsack | lipidmaps | metabolights | metacyc | metanetx | nci | pubchem | reactome | rhea | sabiork | seed | slm | No synonyms |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| e_coli_core | 72 | 72 | 70 | 0 | 72 | 0 | 0 | 32 | 69 | 0 | 72 | 71 | 0 | 10 | 0 | 70 | 72 | 0 | 0 | 61 | 0 | 70 | 72 | 3 | 0 |
| Model | Total | Metabolic rxns | Exchange rxns | Sink rxns | Transport rxns | Demand rxns | Deactivated rxns |
|---|---|---|---|---|---|---|---|
| e_coli_core | 95 | 50 | 7 | 0 | 25 | 13 | 0 |
| Model | Total | bigg | biocyc | cas | chebi | chemspider | drugbank | envipath | hmdb | inchi | inchi_key | kegg | knapsack | lipidmaps | metabolights | metacyc | metanetx | nci | pubchem | reactome | rhea | sabiork | seed | slm | No synonyms |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| e_coli_core | 50 | 50 | 38 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 46 | 0 | 0 | 0 | 33 | 50 | 0 | 0 | 19 | 46 | 40 | 46 | 0 | 0 |
| Carbohydrate metabolism | ||||||||
|---|---|---|---|---|---|---|---|---|
| Central carbohydrate metabolism | Other carbohydrate metabolism | |||||||
| Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P | Glycolysis, core module involving three-carbon compounds | Pyruvate oxidation, pyruvate => acetyl-CoA | Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P | Gluconeogenesis, oxaloacetate => fructose-6P | Citrate cycle (TCA cycle, Krebs cycle) | Methylaspartate cycle | Glyoxylate cycle | |
| e_coli_core | Entire module: 2R01528, R02035 (2 reactions) (67%)Blocked rxns: 0 Essential rxns: 0 | Entire module: 6R01015, R00200, R01512, R01518, R01061, R00658 (6 reactions) (86%)Blocked rxns: 0 Essential rxns: 4R01512, R01061, R00658, R01518 | Entire module: 1R00209 (1 reactions) (20%)Blocked rxns: 0 Essential rxns: 0 | Entire module: 4R01827, R01529, R01830, R01056 (4 reactions) (80%)Blocked rxns: 0 Essential rxns: 1R01056 | Entire module: 6R01015, R01512, R01518, R00341, R01061, R00658 (6 reactions) (75%)Blocked rxns: 0 Essential rxns: 4R01512, R01061, R00658, R01518 | Entire module: 6R01325, R01082, R00405, R00342, R00351, R01900, R00267 (7 reactions) (54%) (R01325, R01900 are present but can not be highlighted on KEGG map)Blocked rxns: 0 Essential rxns: 4R01325, R01900, R00267, R00351 | Entire module: 5R01325, R00248, R00342, R00351, R01900 (5 reactions) (36%)Blocked rxns: 0 Essential rxns: 3R01325, R01900, R00351 | Entire module: 6R01325, R00479, R00342, R00351, R00472, R01900 (6 reactions) (100%)Blocked rxns: 0 Essential rxns: 3R01325, R01900, R00351 |
| Energy metabolism | ||||||||
|---|---|---|---|---|---|---|---|---|
| Carbon fixation | Methane metabolism | |||||||
| Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P | CAM (Crassulacean acid metabolism), light | C4-dicarboxylic acid cycle, NAD - malic enzyme type | CAM (Crassulacean acid metabolism), dark | Reductive citrate cycle (Arnon-Buchanan cycle) | Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate | Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate | Formaldehyde assimilation, ribulose monophosphate pathway | |
| e_coli_core | Entire module: 4R00762, R01056, R01067, R01068 (4 reactions) (57%)Blocked rxns: 0 Essential rxns: 1R01056 | Entire module: 1R00216 (1 reactions) (50%)Blocked rxns: 0 Essential rxns: 0 | Entire module: 3R00342, R00214, R00345 (3 reactions) (38%)Blocked rxns: 0 Essential rxns: 0 | Entire module: 2R00342, R00345 (2 reactions) (100%)Blocked rxns: 0 Essential rxns: 0 | Entire module: 9R01325, R01082, R00405, R00345, R00342, R00199, R01900, R00402, R00267 (9 reactions) (60%)Blocked rxns: 0 Essential rxns: 3R01325, R01900, R00267 | Entire module: 2R00315, R00230 (2 reactions) (100%)Blocked rxns: 0 Essential rxns: 0 | Entire module: 4R01082, R10660, R00342, R00405 (4 reactions) (57%)Blocked rxns: 0 Essential rxns: 0 | Entire module: 2R00756, R01068 (2 reactions) (25%)Blocked rxns: 0 Essential rxns: 0 |
| Nucleotide metabolism | |
|---|---|
| Purine metabolism | |
| Adenine ribonucleotide biosynthesis, IMP => ADP,ATP | |
| e_coli_core | Entire module: 2R00127, R00200 (2 reactions) (50%)Blocked rxns: 0 Essential rxns: 0 |
| Xenobiotics biodegradation | |
|---|---|
| Aromatics degradation | |
| Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA | |
| e_coli_core | Entire module: 1R00228 (1 reactions) (6%)Blocked rxns: 0 Essential rxns: 0 |
| ammonia assimilation cycle III | Calvin-Benson-Bassham cycle | gluconeogenesis I | L-glutamine degradation I | L-glutamine degradation II | superpathway of glycol metabolism and degradation | superpathway of glycolysis and the Entner-Doudoroff pathway | superpathway of glycolysis, pyruvate dehydrogenase, TCA, and glyoxylate bypass | glyoxylate cycle | pentose phosphate pathway (oxidative branch) I | |
|---|---|---|---|---|---|---|---|---|---|---|
| e_coli_core | Entire module: 2 (100%)GLUTAMATESYN-RXN, GLUTAMINESYN-RXN Blocked rxns: 0 Essential rxns: 1GLUTAMINESYN-RXN | Entire module: 6 (46%)F16BDEPHOS-RXN, PHOSGLYPHOS-RXN, 2TRANSKETO-RXN, TRIOSEPISOMERIZATION-RXN, F16ALDOLASE-RXN, RIBULP3EPIM-RXN Blocked rxns: 0 Essential rxns: 1PHOSGLYPHOS-RXN | Entire module: 13 (100%)GAPOXNPHOSPHN-RXN, F16BDEPHOS-RXN, PGLUCISOM-RXN, 1.1.1.39-RXN, PHOSGLYPHOS-RXN, PEPCARBOXYKIN-RXN, TRIOSEPISOMERIZATION-RXN, MALIC-NADP-RXN, F16ALDOLASE-RXN, 2PGADEHYDRAT-RXN, MALATE-DEH-RXN, PEPSYNTH-RXN, 3PGAREARR-RXN Blocked rxns: 0 Essential rxns: 42PGADEHYDRAT-RXN, GAPOXNPHOSPHN-RXN, PHOSGLYPHOS-RXN, 3PGAREARR-RXN | Entire module: 1 (100%)GLUTAMIN-RXN Blocked rxns: 0 Essential rxns: 0 | Entire module: 1 (100%)GLUTAMATESYN-RXN Blocked rxns: 0 Essential rxns: 0 | Entire module: 1 (14%)MALSYN-RXN Blocked rxns: 0 Essential rxns: 0 | Entire module: 14 (88%)PEPSYNTH-RXN, RXN-15513, F16BDEPHOS-RXN, PGLUCISOM-RXN, PHOSGLYPHOS-RXN, 6PFRUCTPHOS-RXN, TRIOSEPISOMERIZATION-RXN, 6PGLUCONOLACT-RXN, GLU6PDEHYDROG-RXN, F16ALDOLASE-RXN, 2PGADEHYDRAT-RXN, GAPOXNPHOSPHN-RXN, PEPDEPHOS-RXN, 3PGAREARR-RXN Blocked rxns: 0 Essential rxns: 5RXN-15513, PHOSGLYPHOS-RXN, 2PGADEHYDRAT-RXN, GAPOXNPHOSPHN-RXN, 3PGAREARR-RXN | Entire module: 20 (80%)RXN-15513, PHOSGLYPHOS-RXN, 6PFRUCTPHOS-RXN, CITSYN-RXN, PYRUVDEH-RXN, ACONITATEDEHYDR-RXN, 2PGADEHYDRAT-RXN, PEPSYNTH-RXN, 3PGAREARR-RXN, MALSYN-RXN, GAPOXNPHOSPHN-RXN, PGLUCISOM-RXN, SUCCCOASYN-RXN, F16BDEPHOS-RXN, TRIOSEPISOMERIZATION-RXN, F16ALDOLASE-RXN, FUMHYDR-RXN, 2OXOGLUTARATEDEH-RXN, MALATE-DEH-RXN, PEPDEPHOS-RXN Blocked rxns: 0 Essential rxns: 7RXN-15513, PHOSGLYPHOS-RXN, CITSYN-RXN, ACONITATEDEHYDR-RXN, 2PGADEHYDRAT-RXN, GAPOXNPHOSPHN-RXN, 3PGAREARR-RXN | Entire module: 4 (67%)MALSYN-RXN, CITSYN-RXN, MALATE-DEH-RXN, ACONITATEDEHYDR-RXN Blocked rxns: 0 Essential rxns: 2CITSYN-RXN, ACONITATEDEHYDR-RXN | Entire module: 3 (100%)GLU6PDEHYDROG-RXN, RXN-9952, 6PGLUCONOLACT-RXN Blocked rxns: 0 Essential rxns: 0 |
| pyruvate fermentation to propanoate I | Bifidobacterium shunt | reductive TCA cycle I | pentose phosphate pathway | 2-aminoethylphosphonate degradation I | sulfoacetaldehyde degradation I | formaldehyde assimilation I (serine pathway) | L-carnitine degradation III | NAD/NADH phosphorylation and dephosphorylation | superpathway of cytosolic glycolysis (plants), pyruvate dehydrogenase and TCA cycle | |
|---|---|---|---|---|---|---|---|---|---|---|
| e_coli_core | Entire module: 2 (29%)MALATE-DEH-RXN, FUMHYDR-RXN Blocked rxns: 0 Essential rxns: 0 | Entire module: 9 (60%)PGLUCISOM-RXN, PHOSGLYPHOS-RXN, RIBULP3EPIM-RXN, ACETATEKIN-RXN, 2PGADEHYDRAT-RXN, GAPOXNPHOSPHN-RXN, PEPDEPHOS-RXN, TRANSALDOL-RXN, 3PGAREARR-RXN Blocked rxns: 0 Essential rxns: 42PGADEHYDRAT-RXN, GAPOXNPHOSPHN-RXN, PHOSGLYPHOS-RXN, 3PGAREARR-RXN | Entire module: 5 (42%)SUCCCOASYN-RXN, ACONITATEDEHYDR-RXN, MALATE-DEH-RXN, FUMHYDR-RXN, PEPSYNTH-RXN Blocked rxns: 0 Essential rxns: 1ACONITATEDEHYDR-RXN | Entire module: 6 (75%)RXN-9952, 2TRANSKETO-RXN, 6PGLUCONOLACT-RXN, GLU6PDEHYDROG-RXN, RIBULP3EPIM-RXN, TRANSALDOL-RXN Blocked rxns: 0 Essential rxns: 0 | Entire module: 1 (33%)ACETALD-DEHYDROG-RXN Blocked rxns: 0 Essential rxns: 0 | Entire module: 1 (50%)PHOSACETYLTRANS-RXN Blocked rxns: 0 Essential rxns: 0 | Entire module: 3 (23%)2PGADEHYDRAT-RXN, MALATE-DEH-RXN, RXN-15513 Blocked rxns: 0 Essential rxns: 22PGADEHYDRAT-RXN, RXN-15513 | Entire module: 1 (33%)1.1.1.39-RXN Blocked rxns: 0 Essential rxns: 0 | Entire module: 1 (17%)PYRNUTRANSHYDROGEN-RXN Blocked rxns: 0 Essential rxns: 0 | Entire module: 14 (64%)PHOSGLYPHOS-RXN, 6PFRUCTPHOS-RXN, 2OXOGLUTARATEDEH-RXN, CITSYN-RXN, MALATE-DEH-RXN, TRIOSEPISOMERIZATION-RXN, ACONITATEDEHYDR-RXN, SUCCCOASYN-RXN, F16ALDOLASE-RXN, 2PGADEHYDRAT-RXN, GAPOXNPHOSPHN-RXN, FUMHYDR-RXN, PEPDEPHOS-RXN, 3PGAREARR-RXN Blocked rxns: 0 Essential rxns: 6PHOSGLYPHOS-RXN, CITSYN-RXN, ACONITATEDEHYDR-RXN, 2PGADEHYDRAT-RXN, GAPOXNPHOSPHN-RXN, 3PGAREARR-RXN |
| pyruvate fermentation to acetate II | pyruvate fermentation to acetate IV | reductive monocarboxylic acid cycle | superpathway of glyoxylate cycle and fatty acid degradation | acetyl-CoA fermentation to butanoate II | Rubisco shunt | vancomycin resistance I | methylaspartate cycle | ammonia assimilation cycle I | ammonia assimilation cycle II | |
|---|---|---|---|---|---|---|---|---|---|---|
| e_coli_core | Entire module: 3 (100%)PHOSACETYLTRANS-RXN, PYRUVDEH-RXN, ACETATEKIN-RXN Blocked rxns: 0 Essential rxns: 0 | Entire module: 3 (100%)PHOSACETYLTRANS-RXN, ACETATEKIN-RXN, PYRUVFORMLY-RXN Blocked rxns: 0 Essential rxns: 0 | Entire module: 1 (50%)PYRUVFORMLY-RXN Blocked rxns: 0 Essential rxns: 0 | Entire module: 6 (43%)PEPCARBOXYKIN-RXN, CITSYN-RXN, ACONITATEDEHYDR-RXN, FUMHYDR-RXN, MALSYN-RXN, MALATE-DEH-RXN Blocked rxns: 0 Essential rxns: 2CITSYN-RXN, ACONITATEDEHYDR-RXN | Entire module: 2 (29%)PHOSACETYLTRANS-RXN, ACETATEKIN-RXN Blocked rxns: 0 Essential rxns: 0 | Entire module: 6 (60%)2TRANSKETO-RXN, 2PGADEHYDRAT-RXN, RIBULP3EPIM-RXN, PEPDEPHOS-RXN, TRANSALDOL-RXN, 3PGAREARR-RXN Blocked rxns: 0 Essential rxns: 22PGADEHYDRAT-RXN, 3PGAREARR-RXN | Entire module: 1 (33%)DLACTDEHYDROGNAD-RXN Blocked rxns: 0 Essential rxns: 0 | Entire module: 5 (26%)CITSYN-RXN, SUCCCOASYN-RXN, ACONITATEDEHYDR-RXN, MALATE-DEH-RXN, FUMHYDR-RXN Blocked rxns: 0 Essential rxns: 2CITSYN-RXN, ACONITATEDEHYDR-RXN | Entire module: 1 (50%)GLUTAMINESYN-RXN Blocked rxns: 0 Essential rxns: 1GLUTAMINESYN-RXN | Entire module: 1 (50%)GLUTAMINESYN-RXN Blocked rxns: 0 Essential rxns: 1GLUTAMINESYN-RXN |
| chitin biosynthesis | adenosine ribonucleotides de novo biosynthesis | superpathway of adenosine nucleotides de novo biosynthesis I | NAD/NADP-NADH/NADPH cytosolic interconversion (yeast) | 1,3-propanediol biosynthesis (engineered) | nitrate reduction VI (assimilatory) | ethanol degradation II | formaldehyde oxidation I | TCA cycle I (prokaryotic) | |
|---|---|---|---|---|---|---|---|---|---|
| e_coli_core | Entire module: 1 (11%)PGLUCISOM-RXN Blocked rxns: 0 Essential rxns: 0 | Entire module: 1 (33%)ADENYL-KIN-RXN Blocked rxns: 0 Essential rxns: 0 | Entire module: 1 (20%)ADENYL-KIN-RXN Blocked rxns: 0 Essential rxns: 0 | Entire module: 1 (20%)GLU6PDEHYDROG-RXN Blocked rxns: 0 Essential rxns: 0 | Entire module: 3 (33%)6PFRUCTPHOS-RXN, PGLUCISOM-RXN, F16ALDOLASE-RXN Blocked rxns: 0 Essential rxns: 0 | Entire module: 2 (50%)GLUTAMINESYN-RXN, GLUTDEHYD-RXN Blocked rxns: 0 Essential rxns: 1GLUTAMINESYN-RXN | Entire module: 1 (33%)ALCOHOL-DEHYDROG-RXN Blocked rxns: 0 Essential rxns: 0 | Entire module: 3 (50%)6PGLUCONOLACT-RXN, PGLUCISOM-RXN, GLU6PDEHYDROG-RXN Blocked rxns: 0 Essential rxns: 0 | Entire module: 6 (60%)CITSYN-RXN, ACONITATEDEHYDR-RXN, FUMHYDR-RXN, 2OXOGLUTARATEDEH-RXN, SUCCCOASYN-RXN, MALATE-DEH-RXN Blocked rxns: 0 Essential rxns: 2CITSYN-RXN, ACONITATEDEHYDR-RXN |
| Growth. The darker the purple, the higher is the flux through the objective function; | No growth; | The model has no reactions that can use the media-specific metabolite as a substrate, making the media growth phenotype identical to the negative control. | FBA fail. |
Model: e_coli_core.xmlObjective reaction: BIOMASS_Ecoli_core_w_GAMExtra metabolites, present in the objective reaction, included on every external media: []Extra metabolites, not present in the objective reaction, included on every external media: ['co2 (carbon dioxide)', 'o2 (oxygen)']Extra metabolites included in the external media when testing carbon sources: []Extra metabolites included in the external media when testing nitrogen sources: []Extra metabolites included in the external media when testing phosphorus sources: []Extra metabolites included in the external media when testing sulfur sources: []
The inclusion of oxygen in the external media might have caused growth in a negative control media.
Overview about the growth phenotype analisis
| No growth on negative control | Total growth | Growth without media-specific metabolites | Total no growth | No growth without media-specific metabolites | FBA failed | True positive (if *E. coli model) | True negative (if *E. coli model) | True negative without media-specific metabolites (if *E. coli model) | False positive (if *E. coli model) | False negative (if *E. coli model) | False negative without media-specific metabolites (if *E. coli model) | Phenotype accuracy (if *E. coli model) |
| 3 out of 4 | 51 | 35 | 332 | 320 | 0 | 36 | 145 | 140 | 5 | 151 | 144 | 53.7 % |
| No growth on negative control | Total growth | Growth without media-specific metabolites | Total no growth | No growth without media-specific metabolites | FBA failed | True positive (if *E. coli model) | True negative (if *E. coli model) | True negative without media-specific metabolites (if *E. coli model) | False positive (if *E. coli model) | False negative (if *E. coli model) | False negative without media-specific metabolites (if *E. coli model) | Phenotype accuracy (if *E. coli model) |
| Yes | 6 | 0 | 185 | 176 | 0 | 5 | 100 | 97 | 0 | 77 | 71 | 57.7 % |
| No growth on negative control | Total growth | Growth without media-specific metabolites | Total no growth | No growth without media-specific metabolites | FBA failed | True positive (if *E. coli model) | True negative (if *E. coli model) | True negative without media-specific metabolites (if *E. coli model) | False positive (if *E. coli model) | False negative (if *E. coli model) | False negative without media-specific metabolites (if *E. coli model) | Phenotype accuracy (if *E. coli model) |
| Yes | 3 | 0 | 93 | 92 | 0 | 2 | 39 | 38 | 0 | 30 | 30 | 57.7 % |
| No growth on negative control | Total growth | Growth without media-specific metabolites | Total no growth | No growth without media-specific metabolites | FBA failed | True positive (if *E. coli model) | True negative (if *E. coli model) | True negative without media-specific metabolites (if *E. coli model) | False positive (if *E. coli model) | False negative (if *E. coli model) | False negative without media-specific metabolites (if *E. coli model) | Phenotype accuracy (if *E. coli model) |
| Yes | 6 | 0 | 54 | 52 | 0 | 6 | 6 | 5 | 0 | 44 | 43 | 21.4 % |
| No growth on negative control | Total growth | Growth without media-specific metabolites | Total no growth | No growth without media-specific metabolites | FBA failed | True positive (if *E. coli model) | True negative (if *E. coli model) | True negative without media-specific metabolites (if *E. coli model) | False positive (if *E. coli model) | False negative (if *E. coli model) | False negative without media-specific metabolites (if *E. coli model) | Phenotype accuracy (if *E. coli model) |
| No | 36 | 35 | 0 | 0 | 0 | 23 | 0 | 0 | 5 | 0 | 0 | 82.1 % |
Biolog Phenotype Microarray Plate 1 - Carbon Sources
| Biolog Phenotype Microarray Plate 2 - Carbon Sources
| Biolog Phenotype Microarray Plate 3 - Nitrogen Sources
| Biolog Phenotype Microarray Plate 4 - Phosphorus and Sulfur Sources
|
|---|